About Head & Neck Cancer Treatment
Head and neck cancer usually starts in the squamous cells that lines the moist, mucosal surface present inside the head and neck. This type of cancer is further categorized by the affected areas such as oral cavity cancer, laryngeal cancer, pharyngeal cancer and other head and neck cancer. Other head and neck cancer includes salivary gland cancer, nasal cavity, and paranasal sinuses cancer.
Technavio’s analysts forecast the global head & neck cancer treatment market to grow at a CAGR of 8.07% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global head & neck cancer treatment market for 2017-2021. To calculate the market size, the report considers sales of both branded and generic drugs in the global head and neck cancer treatment market.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Head & neck cancer treatment market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bristol-Myers Squibb
• Eli Lilly
• Merck
• Pfizer
Other prominent vendors
• Amgen
• Dr. Reddy's Laboratories
• GlaxoSmithKline
• Mylan
• Sun Pharmaceutical Industries
• Takeda Pharmaceuticals
• Teva Pharmaceuticals
Market driver
• Rising incidence of head and neck cancer
• For a full, detailed list, view our report
Market challenge
• Severe side effects of drugs
• For a full, detailed list, view our report
Market trend
• Outpatient care for head and neck cancer patients
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
• Head and neck cancer disease overview
PART 05: Market introduction
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Pipe line landscape
PART 07: Market segmentation by cancer type
• Oral cavity cancer
• Laryngeal Cancer
• Pharyngeal Cancer
• Other head and neck cancer
PART 08: Geographical segmentation
• Head and neck cancer treatment market in Americas
• Head and neck cancer treatment market in EMEA
• Head and neck cancer treatment market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Combination therapy
• Outpatient care for head and neck cancer patients
• Increasing consolidation in cancer treatment market
PART 12: Vendor landscape
• Competitive scenario
PART 13: Key vendor analysis
• Bristol-Myers Squibb
• Eli Lilly
• Merck
• Pfizer
• Other prominent vendor
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Major areas affected by head and neck cancer
Exhibit 02: Symptoms and diagnosis of head and cancer
Exhibit 03: Treatment options for head and neck cancer
Exhibit 04: Global head and neck market snapshot
Exhibit 05: Global head and neck cancer treatment market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis in global head and neck cancer treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Pipeline analysis
Exhibit 09: Global head and neck cancer treatment market by cancer type 2016
Exhibit 10: Market share of global head and neck cancer treatment market by cancer type
Exhibit 11: Global oral cavity cancer treatment market 2016-2021 ($ millions)
Exhibit 12: Median survival rate of oral cavity cancer
Exhibit 13: Stages of laryngeal cancer
Exhibit 14: Global laryngeal cancer treatment market 2016-2021 ($ millions)
Exhibit 15: Types of pharyngeal cancer
Exhibit 16: Global pharyngeal cancer treatment market 2016-2021 ($ millions)
Exhibit 17: Global other segment for head and neck cancer treatment market 2016-2021 ($ millions)
Exhibit 18: Global head and neck cancer treatment market by geography 2016 and 2021
Exhibit 19: Head and neck cancer treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 20: Market scenario in Americas
Exhibit 21: Head and neck treatment market in Americas 2016-2021 ($ millions)
Exhibit 22: Market scenario in EMEA
Exhibit 23: Head and neck treatment market in EMEA 2016-2021 ($ millions)
Exhibit 24: Head and neck treatment market in APAC 2016-2021 ($ millions)
Exhibit 25: Percentage distribution of population aging 60 years and above 2015-2050
Exhibit 26: Competitive structure analysis of head and neck cancer treatment market 2016
Exhibit 27: Strategic success factors of companies in global stem cell therapy market
Exhibit 28: Key highlights
Exhibit 29: BMS: Strength assessment
Exhibit 30: BMS: Strategy assessment
Exhibit 31: BMS: Opportunity assessment
Exhibit 32: Eli Lilly: Key highlights
Exhibit 33: Eli Lilly: Strength assessment
Exhibit 34: Eli Lilly: Strategy assessment
Exhibit 35: Eli Lilly: Opportunity assessment
Exhibit 36: Merck: Key highlights
Exhibit 37: Merck: Strength assessment
Exhibit 38: Merck Strategy assessment
Exhibit 39: Merck: Opportunity assessment
Exhibit 40: Pfizer: Key highlights
Exhibit 41: Pfizer: Strength assessment
Exhibit 42: Pfizer: Strategy assessment
Exhibit 43: Pfizer: Opportunity assessment
